NL-OMON55522已完成不适用
Diagnostic value of soluble CD14 subtype in neonatal sepsis - Diagnostic value of soluble CD14 subtype in neonatal sepsis
OLVG0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 0 至 0（—）
入选标准
- •Admitted to the Neonatal unit
- •Undergoing sepsis evaluation according to the Dutch early onset neonatal
- •sepsis guideline, or local late-onset sepsis guideline.
- •Informed consent of parents or legal guardian(s)
排除标准
- •Confirmed intrauterine infection (toxoplasmosis, rubella, cytomegalovirus,
- •syphilis and herpes)
研究者
相似试验
已完成
不适用
Soluble CD14 subtype (presepsin) levels in the scheduled high-risk surgery patients who candidates ICU admission ; a prospective observational studythe scheduled high-risk surgery patientsJPRN-UMIN000013748Fujita Health University School of Medicine Department of Anesthesiology and Critical Care Medicine150
已完成
不适用
Increased presepsin (soluble CD14 subtype) values in surgical patients with chronic kidney disease on hemodialysis even in the absence of infectioSurgical patients with chronic kidney disease on hemodialysis in the absence of infectionJPRN-UMIN000015592Hirosaki University Graduate School of Medicine, Department of Anesthesiology60
已完成
不适用
Serum CD14 and CD88 Mointoring in ICUSepsisNCT02120534Tanta University80
已完成
不适用
Correlation of CD147 Expression in Stage-IV Non-Small Cell Lung Cancer with Platinum-Based Chemotherapy Treatment OutcomesStage-IV Non-CD147 (EMMPRIN)advanced stage non-cisplatin-based chemotherapytreatment outcomesSmall Cell Lung Cancersmall cell lung cancerTCTR20190308002Prince of Songkla University242
进行中（未招募）
不适用
Bridging study using ch14.18/CHO antibody in children with refractory neuroblastomaneuroblastomaEUCTR2005-001267-63-ATSt. Anna Kinderspital18